Full List Of Stories
Week ahead: Bank of England, US non-farm payrolls in focus
Investors' focus over the coming week will be firmly on the Bank of England, as rate-setters meet on Thursday to decide on monetary policy.
Europe close: End of month drubbing for healthcare and banks
European stocks finished January on a sharply down note as investors fretted about stockmarket valuations and Covid vaccine supplies on the Continent, after a week in which a web-inspired group of small investors took on large US hedge funds.
Novartis inks deal to help Pfizer-BioNTech ramp up output of Covid-19 vaccine
Switzerland's Novartis AG has inked a deal with Pfizer-BioNTech aimed at boosting the world's output of Covid-19 vaccines.
BofA sees 'correction' ahead in stockmarkets
Strategists at Bank of America are anticipating a 'correction' in global stockmarkets over the next few months but within the context of more enduring changes in the backdrop for financial markets.
US SEC warns market participants to follow rules, warns on volatility
America's stockmarket regulator warned of the possible fallout from the recent sharp volatility in the share prices of smaller firms.
Novavax Covid-19 vaccine nearly 90 per cent effective, less so in South Africa
Novavax's Covid-19 vaccine candidate achieved a very high efficacy, the results of the company's late-stage clinical trials showed.
Sector movers: Insurers and defensives weigh on market
Life Insurance was the weakest segment of the FTSE 350 even as risk appetite rebounded in financial markets around the globe, although strength in the pound continued to act as a headwind for UK stocks.
Sector movers: Insurers and defensives weigh on market
Life Insurance was the weakest segment of the FTSE 350 even as risk appetite rebounded in financial markets around the globe, although strength in the pound continued to act as a headwind for UK stocks.